(Q38281749)

1 September 2017

1 reference

title

Myositis specific and associated autoantibodies in the diagnosis and management of juvenile and adult idiopathic inflammatory myopathies (English)

1 reference

1 September 2017

1 reference

1 reference

Sarah L Tansley

1

0 references

author name string

Neil J McHugh

series ordinal

2

1 reference

1 September 2017

publication date

1 December 2014

1 reference

Current Rheumatology Reports

1 September 2017

published in

1 reference

1 September 2017

volume

16

1 reference

1 September 2017

issue

12

1 reference

1 September 2017

page(s)

464

1 reference

Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Clinically amyopathic dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Prevalence of sporadic inclusion body myositis in Western Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Comparison of radioimmunoprecipitation versus antigen-specific assays for identification of myositis-specific autoantibodies in dermatomyositis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

The multicenter study of a new assay for simultaneous detection of multiple anti-aminoacyl-tRNA synthetases in myositis and interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

21 January 2018

Myositis autoantibodies

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Identification of a novel autoantibody directed against small ubiquitin-like modifier activating enzyme in dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Anti-SAE antibodies in autoimmune myositis: identification by unlabelled protein immunoprecipitation in an Italian patient cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Clinical and human leucocyte antigen class II haplotype associations of autoantibodies to small ubiquitin-like modifier enzyme, a dermatomyositis-specific autoantigen target, in UK Caucasian adult-onset myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

A systematic review of juvenile-onset clinically amyopathic dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Necrotizing autoimmune myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Inclusion body myositis: clinical and pathological boundaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Autoantibodies against a 43 KDa muscle protein in inclusion body myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Autoantibody profiles in the sera of European patients with myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Characteristics of interstitial lung disease in SS-A positive/Jo-1 positive inflammatory myopathy patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)--clinical characteristics of children recruited within the first 5 yr.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Anti-NXP2 autoantibodies in adult patients with idiopathic inflammatory myopathies: possible association with malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Disappearance of anti-MDA-5 autoantibodies in clinically amyopathic DM/interstitial lung disease during disease remission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Predictors of acquired lipodystrophy in juvenile-onset dermatomyositis and a gradient of severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

A47: Progress Report on the Development of New Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-014-0464-1

A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis

21 January 2018

1 reference

12 December 2020

Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases

1 reference

12 December 2020

Detection of antisynthetase syndrome in patients with idiopathic interstitial pneumonias

1 reference

12 December 2020

Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis

1 reference

12 December 2020

Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population

1 reference

12 December 2020

Clinical and laboratory features of overlap syndromes of idiopathic inflammatory myopathies associated with systemic lupus erythematosus, systemic sclerosis, or rheumatoid arthritis

1 reference

12 December 2020

In patients with antisynthetase syndrome the occurrence of anti-Ro/SSA antibodies causes a more severe interstitial lung disease

1 reference

12 December 2020

Cytoplasmic 5'-nucleotidase autoantibodies in inclusion body myositis: Isotypes and diagnostic utility

1 reference

12 December 2020

Anti-PM-Scl antibody in patients with systemic sclerosis.

1 reference

12 December 2020

Anti-TIF1γ antibodies (anti-p155) in adult patients with dermatomyositis: comparison of different diagnostic assays

1 reference

12 December 2020

Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody

1 reference

12 December 2020

Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis

1 reference

12 December 2020

Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis

1 reference

12 December 2020

Diagnosis of interstitial lung diseases.

1 reference

12 December 2020

Analysis of autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme A reductase using different technologies

1 reference

12 December 2020

Anti-melanoma differentiation-associated gene 5 antibody is a diagnostic and predictive marker for interstitial lung diseases associated with juvenile dermatomyositis

1 reference

12 December 2020

Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis

1 reference

12 December 2020

Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy

1 reference

12 December 2020

Low prevalence of anti-small ubiquitin-like modifier activating enzyme antibodies in dermatomyositis patients

1 reference

12 December 2020

10.1007/S11926-014-0464-1

Identifiers

DOI

1 reference

Dimensions Publication ID

1 September 2017

1016404385

0 references

1 reference